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The potentially fatal condition of Acute Respiratory Distress Syndrome (ARDS) begins 
with damage to the lung, which then becomes flooded with fluid rich in serum protein. These 
serum proteins inactivate the lung surfactant (LS) that lines the alveoli, raising alveolar surface 
tension and resulting in lung collapse. Previous studies have shown that the addition of nonionic 
polymers to therapeutic replacement lung surfactant (RLS) restores the surface activity of RLS in 
the presence of inactivating substances, a possible explanation being the dehydration of RLS 
vesicles by polymer-induced depletion forces. This study tested the hypothesis that RLS whose 
surface activity responds to the addition of polymer will also experience dehydration upon 
application of known osmotic stress. 
The interlamellar spacing d of the porcine extract RLS Curosurf and the synthetic RLS 
Exosurf was measured using small-angle X-ray scattering in the presence of polymer and/or 
bovine serum albumin (BSA) at various concentrations. The applied osmotic pressures were 100 
– 108 dynes/cm2. Over this range of pressures, Curosurf experiences a 50Å change in d that fits 
an exponential curve with decay constant of 7.22 ± 0.23 Å, similar to the Debye length in 150 
mM solution. This may indicate the presence of electrostatic interactions. The Exosurf d lie 
within a range of 59-72 Å but exhibit no definite trend. These results suggest that added polymer 
in the concentrations utilized would not improve the surface activity of Exosurf, but that osmotic 
stress may indeed be a mechanism by which polymers restore the function of inactivated 
Curosurf.   Polymers  used  were  polyethylene glycol (PEG, 10 or 20 kDa) and 150 kDa Dextran.
To investigate the effect of PEG on the surface activity of Exosurf, pressure-area 
isotherms of Exosurf spread from chloroform on 150 mM NaCl, 5 mM CaCl2, 1.5 mM tris-HCl, 
pH 7.2-7.4, were recorded at 24.5ºC in the presence and absence of 5% PEG (m.w. 10 kDa) and 
2  mg/mL BSA. Upon repeated compressions of Exosurf on 5% PEG solution, a decrease in the 
length of the fluid-condensed phase coexistence region in the isotherm suggested the dissolution 
of Tyloxapol into the subphase.  
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1. INTRODUCTION 
The lipids and proteins which comprise natural lung surfactant (LS) are secreted by the 
alveolar type II cells of the lung, and exist in the fluid lining of the alveoli as lamellar aggregates, 
vesicles, tubular myelin structures, and a monolayer at the air-water interface[1]. The monolayer 
undergoes reversible phase transitions as the area available to it changes during breathing. Its 
primary function is to reduce surface tension in an area-dependent fashion so that the surface 
tension is near zero when the alveoli are smallest. The relationship between low surface tension 
and lung surfactant function is described in Section 2.1.1. NRDS (neonatal respiratory distress 
syndrome) results from LS deficiency. Elevated alveolar surface tensions cause lung collapse, 
reducing lung volume, injuring lung tissue, and decreasing blood oxygenation [2]. ARDS 
(acute respiratory distress syndrome) shares many symptoms with NRDS, but stems from
surfactant inactivation rather than surfactant deficiency and can furthermore occur at all ages; 
NRDS is limited to infants born before LS production begins.
ARDS is a vicious cycle that begins with damage to the lung, which then becomes 
flooded with fluid rich in serum protein. These serum proteins inactivate the surfactant lining the 
alveoli. Lung collapse can result from increased surface tension within the alveoli; the 
subsequent stretching of surfactant-deficient alveolar structures produces further damage [3].
In 50% of patients, respiratory distress develops within 24 hours of the initial insult [4], 
which provides a window of opportunity for prophylactic treatment. Though the body's repair 
of lung tissue begins within 7 to 28 days, lasting respiratory impairment is common, and the 
healing process may continue for up to 12 months [5]. An NIH study in 1972 found 150,000 
cases of ARDS per year [6]; this has been widely cited but may be an overestimate [4]. Physical trauma  
and aspiration of gastric contents are common initiators of ARDS [4].  
 Table 1 describes the composition of three commercially available replacement lung 
surfactants (RLS): Exosurf, Curosurf, and Survanta. Curosurf is an organic extract of minced 
porcine lungs, suspended in 150 mM NaCl. Its primary components are phosphatidylcholine, 
phosphatidylethanolamine, and sphingomyelin, which are all neutral phospholipids; it also 
contains a total of 6 % charged lipids. Survanta is an organic extract of minced bovine lung, to 
which dipalmitoylphosphatidylcholine (DPPC), palmitic acid (PA), and tripalmitin have been 
added. Both Survanta and Curosurf also contain a small amount of surfactant proteins SP-B and 
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 SP-C.  Exosurf is a completely synthetic, protein-free RLS whose possible advantages include 
low cost and well-defined composition [7]. However, it is less effective than Curosurf or 
Survanta in the treatment of NRDS [8]. 6% of its composition is a non-biological surfactant 
(Tyloxapol). 
 
Name Source 
(animal/synthetic) 
Composition Manufacturer 
Exosurf Synthetic  
in 100 mM NaCl 
85 % DPPC 
9% hexadecanol 
6% tyloxapol [9,10] 
 
GlaxoSmithKline, 
USA 
Curosurf  Minced porcine lung 
extract 
 in 150 mM NaCl 
99 % phospholipid 
1% surfactant protein  (SP-B, SP-C) 
Phospholipid Content: ~64% PC,  
~12% PE, ~10% SPH, ~2% each of 
PI/PG/PS [11] 
 
Chiesi Farmaceutici, 
Italy 
Survanta Minced bovine lung 
extract,  + DPPC, PA 
and tripalmitin; 
cholesterol removed 
in 150 mM NaCl  
 
 
25 mg/mL phospholipids, incl. 11.0-
15.5 mg/mL DPPC  
  
0.5-1.75 mg/mL triglycerides,  
> 1 mg/mL SP-B, SP-C [7] 
Abbott Laboratories, 
USA  
 
Table 1. Some replacement lung surfactant compositions. DPPC: dipalmitoylphosphatidylcholine.  
PC: phosphatidylcholine. PE: phosphatidylethanolamine. SPH: sphingomyelin. PI: phosphatidylinositol.  
PG: phosphatidylglycerol.  PS: phosphatidylserine. 
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  While RLS therapy has dramatically reduced mortality in NRDS, the inactivation of RLS 
by serum proteins, meconium (neonatal feces) and other substances has hindered the use of 
RLS therapy for ARDS patients. The development of an inactivation-resistant RLS is thus a 
desirable goal [12]. Taeusch[13] and Kobayashi[14], working independently of each other, 
demonstrated that addition of nonionic polymers such as polyethylene glycol or dextran permits 
RLS to maintain low surface tensions and rapid adsorption rates even in the presence of 
substances known to inactivate LS. These groups modeled the alveolus using a modified 
pulsating bubble surfactometer [15], which consists of a chamber filled with surfactant solution 
into which a bubble is introduced via an air-filled dry capillary. Pressures applied to this solution 
via a piston cause the bubble to shrink or expand, mimicking the deflation and inflation of an 
alveolus during breathing. Surface tension is determined using the Young-Laplace equation 
(Equation 1) and the bubble’s radius. 
Selected findings from Taeusch are plotted in Figure 1 for mixtures of Survanta, 
Curosurf, and various polymers in the presence and absence of meconium, which is fecal matter 
sometimes inhaled by infants during birth. The polymers utilized were polyethylene glycol, 
dextran (a glucose polymer), and polyvinylpyrrolidone. Minimum surface tension (γmin) was 
measured after the tenth deflation in the pulsating bubble surfactometer described above. While 
the γmin of unadulterated Survanta rises from approximately 3 mN/m to 30 mN/m at 3% 
meconium, the γmin of the Survanta – polymer mixtures remains near zero at all meconium 
concentrations. This is comparable to the behavior of whole dog surfactant, and an improvement 
over a mixture of  Survanta and surfactant protein A (SP-A), a glycoprotein abundant in natural 
lung surfactant. Figure 2 shows complementary results from Tashiro and coworkers [16], who 
found that addition of dextran lowered the γmin of a Curosurf mixture to which 5 mg/mL 
meconium had been added. The minimum surface tension of the mixture fell from approximately 
22 mN/m (unadulterated Curosurf plus meconium) to about 2 mN/m with the addition of 10 
mg/mL dextran.   
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Figure 1 . Minimum surface tension after tenth bubble deflation in a pulsating bubble surfactometer, in the 
presence or absence of meconium. Solvent is 0.9% NaCl, 5mM HEPES, pH 7.0-7.2, at 37ºC. Data is re-plotted 
from Taeusch et al, AJRCCM 1999. 
(a) Mixtures of Survanta (1.25 mg/mL) with polymer or surfactant protein A.  
(b) Whole dog surfactant, or mixtures of buffer with polymer. 
 
 
Figure 2. Effect of meconium and dextran on the minimum surface tension of Curosurf, measured with a 
pulsating bubble surfactometer.  Data is re-plotted from Tashiro et al, Acta Paediatr 2000.  
 
 While polymer interactions with lipid membranes have been extensively characterized 
[17-19] [20] [21], their application to multicomponent aggregates of lung surfactant was first 
proposed by Taeusch [13], who suggested that the behavior of LS-polymer mixtures may be 
related to polymer exclusion from lipid vesicles. The resulting osmotic stress may have 
ramifications for a variety of surfactant characteristics, including adsorption rate and 
concentration of surface-associated lipids [12]. 
4 
  We wish to directly determine if and how osmotic stress affects RLS whose surface 
activity responds to the addition of polymer. The interactions between hydrophilic polymers and 
lipid membranes may include polymer exclusion from the membrane surface, with a resulting 
depletion attraction [22], but could also involve repulsive forces if the polymer were to adsorb 
onto the membranes [23]. If the polymer is neither attracted to nor repelled from the membrane 
surface, no forces will be exerted by it, and the above mechanisms can be eliminated from the 
possible modes of polymer-vesicle interaction.  
Our data shows that Curosurf, a porcine extract surfactant for which the interfacial effects of 
polymer include decreased adsorption time and lower minimum surface tension [16], exhibits a 
reduction in interlamellar spacing upon application of 100 – 108 dyne/cm2 osmotic pressure. This 
indicates that osmotic stress does draw water out of Curosurf vesicles and may contribute to 
Curosurf’s improved surface activity upon the addition of polymer. Exosurf, a protein-free 
synthetic surfactant, exhibits no definite trend; the data is distributed over a 10Å range that does 
not appear to depend on the exerted pressures. We therefore predict that polymer addition will 
not improve Exosurf’s ability to lower surface tension in the presence of substances known to 
inactivate LS.   
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2. BACKGROUND 
2.1.Biological function of lung surfactant 
An effective lung surfactant must be able to: 
(1) reach a minimum surface tension γmin near zero mN/m at small alveolar surface areas 
upon dynamic compression.   
(2) exhibit an equilibrium surface tension (γeq) of 25 mN/m 
(3) adsorb rapidly to coat the entire alveolar interface 
The definition of, and rationale for, each of these criteria is described below.  
 
2.1.1. Minimum surface tension of zero upon dynamic compression 
The minimum surface tension, γmin , is a non-equilibrium property obtained by reducing 
the amount of surface area available to the surfactant monolayer, so that the concentration of 
molecules at the interface is greater than at equilibrium The surface tension γmin is thus lower 
than the equilibrium surface tension γeq. 
 The lung contains over 300 million alveoli, lined with surfactant-containing fluid and 
possessing a total internal surface area of about 70 m2. Inflation of the lung is achieved by 
contraction of the diaphragm, which expands the volume of the thoracic cavity. This decreases 
the pressure within the alveoli; air thus flows into the lung. The reduction in surface tension due 
to the action of lung surfactant is essential to this process [2]. 
A spherical fluid cavity with radius of curvature R requires an inflation pressure ∆P that 
is related to the fluid’s surface tension by the Young-Laplace equation [24].   
R
P γ2=∆  
Equation 1. The Young-Laplace equation for a spherical curved surface. 
 
The alveoli can be represented as connected cavities in the alveolar fluid. On average, 
each alveolus has radius 0.05 mm at rest and 0.1 mm when inflated. In premature infants lacking 
surfactant, the alveolar fluid has the surface tension of water, approximately 70 millinewtons per 
meter at 37ºC. Under these conditions, a deflated alveolus would need to contain 21.7 mm Hg 
6 
 greater pressure than atmospheric (the pressure within the thoracic cavity surrounding the 
alveoli) to maintain its radius of 0.05 mm. An inflated alveolus would require +10.9 mm Hg to 
maintain its radius of 0.10 mm. The decrease in pressure compared to the deflated alveolus 
would drive the flow of air into the lung.  
 
( ) mmHg
psi
mmHg
cmdyne
psicmdyne
cm
cmdyne
r
Pdef 7.21696.14
760
/
000015.0/28000
005.0
/7022
2
2 =⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛===∆ γ  
( ) mmHg
psi
mmHg
cmdyne
psicmdyne
cm
cmdyne
r
P 9.10
696.14
760
/
000015.0/14000
01.0
/7022
2
2
inf =⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛===∆ γ   
 
However, at rest ∆Pdef is zero; the alveoli contain atmospheric pressure. The expansion of 
the thoracic cavity only reduces the internal alveolar pressure by 1-2 mm Hg.  Surface tension 
must therefore be reduced to zero in order for the alveoli to remain inflated at rest, and to inflate 
with such a small pressure decrease. [2] 
 
2.1.2. Reach equilibrium surface tension of 25 mN/m 
γeq is related to bulk concentration by the Gibbs surface excess , which is the excess 
amount of solute adsorbed per unit surface area of a liquid[25,26]. The extent of solute 
adsorption can be calculated from the Gibbs adsorption equation using data on the change in γ
1
2Γ
eq 
with molar or molal solute concentration c2.  
⎟⎟⎠
⎞
⎜⎜⎝
⎛−=Γ
2
1
2 ln
1
cd
d
RT
γ  
Equation 2. The Gibbs adsorption equation. 
 
A 5 mg/mL solution of natural LS in 0.15 mM NaCl and 5 mM CaCl2, extracted by saline 
lavage of calf lungs, reaches γeq of 25 mN/m after 10 s of adsorption in a pulsating bubble 
apparatus. Calf lung extract surfactant (CLSE), obtained by chloroform:methanol extraction, also 
reaches γeq of 25 mN/m under the same conditions [27].  An RLS that most closely approximates 
the behavior of natural LS must therefore exhibit similar γeq.    
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 2.1.3. Adsorb rapidly to coat the interface 
Lipid aggregates closely associated with the interface are said to play an important role in 
adsorption. For example, small vesicles of DPPC adsorb more rapidly and lower surface tension 
more effectively than large liposomes [28].  Surfactant subtypes of different morphologies, 
varying in concentration of surfactant protein, exhibit different surface activities though their 
phospholipid content is identical [1]. A more detailed explanation of the relationship between 
aggregate structure and adsorption is given in the "Lipid Mechanics" section of this paper. Here, 
characteristics of adsorption relevant to lung surfactant are described. 
During inhalation to total lung capacity (TLC), it is necessary that surfactant adsorb 
rapidly so that low surface tensions can be maintained and a single breath is sufficient to bring 
new surfactant to the interface. [29]. Surfactant concentration and composition both govern 
adsorption rate; for example, a 1 mg/mL suspension of bovine lipid extract surfactant (bLES) 
reaches a γeq of 25 mN/m in just 5 seconds, while a 200 microgram-mL suspension of the same 
surfactant requires over 30 seconds to reach the same surface tension [30]. In contrast, a 100 
microgram/mL suspension of Exosurf reaches a γeq of 34.5 ± 0.5 mN/m in 15 minutes, indicating 
that Exosurf may perform poorly as a replacement lung surfactant compared to bLES. 
Rapid adsorption appears to take place incrementally, where surface tension decreases 
with step sizes ranging from 1 to 10 mN/m. These adsorption "clicks", so named because they 
cause a captive bubble to suddenly change height in a clicking fashion, are ascribed to aggregates 
containing approximately 1014 molecules of DPPC and 1011 molecules of surfactant proteins (a 
mixture of SP-B and SP-C) [29]  
Adsorption to γeq yields a reservoir of surfactant aggregates remaining closely associated 
with the surface monolayer. Schurch [29] demonstrated this by introducing an air bubble into a 
solution of Curosurf, allowing the surfactant to adsorb, then carefully replacing all of the bulk 
solution with surfactant-free saline. The bubble was then expanded by moving a piston that 
increased the sample chamber volume. Expanding the bubble past its original size should have 
increased the surface tension above the equilibrium value if the surfactant had only formed a 
monolayer; however, the observed plateau in surface tension indicated that excess material had 
also been associated with the interface. Continuing to compress the surface film past the point of 
γmin yields a collapse phase in addition to this reservoir [30]. 
8 
 2.2.Inhibition of replacement lung surfactant 
 While the fibrin monomer is the most potent inhibitor of lung surfactant (LS), albumin 
comprises a larger fraction of the total serum proteins [31] and is therefore the inhibitor of 
interest in this paper. Previous studies have concluded that albumin inactivates LS by 
competition for the interface[27,32,33]. Warriner and coworkers furthermore found that albumin 
inserts into model LS monolayers at a surface pressure equal to the surface pressure of the bulk 
albumin solution[34]. When the albumin concentration was changed, so did the bulk solution 
surface pressure and therefore the insertion pressure. The albumin at the surface reduced the area 
available to the LS molecules, preventing respreading of collapsed material. Since the collapsed 
LS could not respread to coat the surface, lower surface pressures prevailed upon subsequent 
compressions of the monolayer. 
  
        
 
Figure 3.  Relationship between inhibition and equilibrium spreading pressure. (a) 69/21/10 wt% 
DPPC/POPG/PA on 25 °C 150 mM NaCl, 2 mM CaCl2, 0.2 mM NaHCO3 , pH 7, 0.5-1 mol% TR-DHPE 
added for imaging.  (b) Same composition as (a). Compressed to A. BSA injected to a final concentration of 2 
mg/mL and allowed to equilibrate. Re-expanded to B, then compressed to C and D. Reprinted with 
permission from Warriner et al,  Biophys. J. 2002.  Copyright (2002) Biophysical Society. 
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 2.3. Osmotic stress 
A non-adsorbing solute draws water from lipid vesicles by initiating a gradient in the
   chemical potential of water. The gradient can be viewed as work (w) done by osmotic pressure
     Posm on a volume of water dV located between or within vesicles.   
dVPw osm−=  
Equation 3. Osmotic pressure does work by changing the volume of water between or within vesicles.  
This can induce aggregation of vesicles surrounded by a depletion layer in polymer solution; or 
reduction in the interlamellar spacing of vesicles where the solute concentration outside the 
vesicles differs from that within them (Figure 4).  The latter situation is considered in this paper; 
both cases are based on thermodynamic concepts summarized by Parsegian [19].
 
Figure 4. Osmotic stress can induce aggregation or reduction in d-spacing of  multilamellar vesicles. 
 
For a solute to exert osmotic stress, its concentration adjacent to the vesicles must 
differ from that in the bulk [19]. This in turn changes the water concentration, which is related
to the water's chemical potential. 
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   The chemical potential of a solute x depends on its concentration Cx , as well as the 
 
solute-solvent interactions and the temperature. This is shown in Equation 4, where σ is the solute
 
activity coefficient1, T  is temperature (Kelvin), and k is Boltzmann’s constant (1.38 x 10-23 J/K). 
 
( )xx CkT σµ ln=  
Equation 4. Dependence of chemical potential on concentration. 
 
 Both vesicular aggregation and movement of lamellae involve movement of mass, 
 
which flows according to gradients in chemical potential. The chemical potential of each
 
component in a solution can affect that of other components.   
Consider a quantity NM of multilamellar vesicles M in a solution of water (w) containing a 
solute (s). The number of water molecules around the vesicles is Nw and the number of solute 
molecules is Ns. The Gibbs-Duhem equation describes the constraints on the free energy of the 
system; namely, that no net effect should result from changes in free energy induced by altering 
the temperature (T), pressure (P), and chemical potential (µ).   
 
( )wwssMM dNdNdNVdPSdT µµµ +++−=0  
Equation 5. Gibbs-Duhem equation for a multilamellar vesicle M in a solution of water (w) and solute (s). 
 
For NM = 1 at constant temperature and pressure, this equation can be rewritten so that 
changes in the vesicle’s chemical potential dµM depend only on changes in the solute and water 
chemical potentials dµs and dµw.  
 
( )wwssM dNdNd µµµ +−=  
Equation 6. Relationship between chemical potentials of components in a solution at constant T and P. 
                                                 
1Though the activity coefficient is often denoted by γ, it is represented by σ here to avoid confusion with the 
notation employed for surface tension.  
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A vesicle-free reference solution can also be defined, where the water and solute quantities 
are represented by nw and ns. These quantities can refer to the environment within the vesicle, or 
concentrations in bulk solution far from the vesicle. At constant temperature and pressure, dµs 
and dµw can be written in terms of each other via the Gibbs-Duhem equation.   
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Equation 7. Chemical potentials of water and solute in a vesicle-free solution at constant T and P.  
 
Replacing dµw in Equation 6 with its definition in Equation 7 yields an expression where 
the change in vesicular chemical potential dµM depends on the bulk concentrations ns and nw.  as 
well as  dµs, Ns  and Nw . Rearrangement of this expression reveals that the ratios Ns / Nw  and ns  / 
nw must differ in order for dµM  to be nonzero. The dependence of dµM on dµw can be derived in a 
similar fashion.   
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Equation 8. The relationship between solute, water, and vesicular chemical potentials depends on the 
differences in concentration around the vesicle.  
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 An example of the dehydration of lipid vesicles by osmotic stress is shown in Figure 5, 
where the chemical potential of water in a vesicular solution was altered using a variety of 
methods that exerted different amounts of osmotic pressure. The lowest-pressure method (P ≤ 10 
atm) involved placing the solution in equilibrium with a polymer solution through a dialysis 
membrane. Higher pressures were applied by piston, where water escaped through a membrane
(6 atm = P = 500 atm), and by equilibration with saturated salt solution whose partial pressure of 
water in the vapor phase was lower than the vapor pressure of pure water (225 atm ≤ P ≤1500 
atm). The lipids were a mixture of phosphatidylcholines obtained from chicken eggs, with 
an average molecular weight of 790. An exponential decrease in d with pressure was observed, 
which corresponded to removal of water from the interlamellar space. The data are replotted in 
Figure 5, with log10P on the y-axis and d (Å) on the x-axis.   
 Figure 5. Dehydration of mixed phosphatidylcholine vesicles by osmotic pressure. Data are replotted from
Parsegian et al, PNAS 1979. 13 
  
2.4.Lipid mechanics 
Liposomes consist of lipid bilayers surrounding an aqueous solution, and can be 
classified into at least three categories: multilamellar vesicles (MLV), small unilamellar vesicles 
(SUV) and large unilamellar vesicles (LUV). Molecular geometry determines whether a mixture 
of lipids will form a vesicle at all [35], while the preparation method can determine whether the 
mixture forms MLVs, SUVs, or LUVs.  MLVs can be prepared by evaporating the solvent from 
an organic solution of lipids and hydrating the resulting thin lipid film with buffer above the 
transition temperature of the highest-melting component[36], which is the method utilized to 
prepare vesicles of Exosurf in the present study.   
Osmotic removal of water from vesicles causes them to decrease in radius and thus 
increase in curvature. The distance dw between lamellae also decreases. Though osmotic stress is 
capable of changing the headgroup area or bilayer thickness dL [17] [20], we assume that these 
dimensions remain constant over the range of applied pressures. This assumption is borne out by 
our observation of the exponential decrease in Curosurf d-spacing with applied pressure; a 
change in dL would have required that some of the applied pressure go into inducing this phase 
transition, which would have disrupted the linear relationship of d with log10P. 
Deformation increases the interfacial free energy of the bilayer, favoring vesicle rupture 
or fusion with flat interfaces [37]. This phenomenon is the basis for our hypothesis regarding the 
mechanism by which PEG helps lung surfactant maintain low surface tensions. 
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Figure 6. Vesicular shrinkage, and the resulting increase in curvature, upon applied osmotic stress.  
  
2.4.1. Curvature dependence of interfacial free energy 
Self-assembly arises from the balance of attractive and repulsive forces between 
amphiphilic molecules.  These interactions can include hydrophobic attractions, depletion 
attractions, steric repulsions, or electrostatic interactions.  The interaction free energy per 
molecule in a bilayer vesicle containing N molecules is given by 
  
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛ −+−+= 222 1122 c
b
oo
o
N RR
kaa
a
a γγµ  
Equation 9. Interaction free energy per molecule in a bilayer vesicle. 
 
where the optimal headgroup area ao and the critical vesicle radius Rc are characteristic of the 
molecule, being based on molecular geometry, while the actual radius R and headgroup area a 
represent features of the specific vesicle. The interfacial energy per molecule γ is calculated at 
the hydrocarbon-water interface, that is, the boundary between the hydrocarbon tails and 
hydrophilic headgroups of the molecules in the bilayer.  The bending modulus kb, on the other 
hand, accounts for repulsions taking place some distance away from this boundary, normal to the 
bilayer. This is illustrated in Figure 7. A negative bending modulus kb indicates that inter-
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 headgroup repulsions are greater than interchain repulsions, favoring bending. A positive kb 
indicates that interchain repulsions dominate, which opposes bending. Therefore the third term in 
Equation 9 expresses free energy contributions from the vesicle curvature. The first term 
indicates the attractive contribution, and the second term indicates the contribution from 
interfacial tension arising from the difference in a compared to ao. [35].  
 
Figure 7. The bending modulus kb accounts for interheadgroup and interchain repulsions taking place 
normal to the hydrocarbon-water interface within the bilayer. 
 
When vesicles adsorb to a flat interface, the bilayer curvature (1/R) goes to zero. This can 
cause a large decrease in free energy if the spontaneous curvature of the lipids is in fact zero. 
Equation 9 shows that vesicles with R < Rc and a ≠ ao will have greater interaction free energy. 
Small, highly curved vesicles composed of lipids with zero spontaneous curvature will undergo a 
greater decrease in free energy upon adsorption onto a flat air-water interface, compared to larger 
vesicles of the same lipids. Therefore, small vesicles adsorb more quickly to the interface. 
Vesicles can be reduced in size by sonication [28] or osmotic removal of water [37].  Adsorption 
can be further facilitated by altering the vesicular lipid composition so that the preferred 
curvature is closer to zero, thus increasing the energy difference between the curved vesicles and 
flat monolayer or bilayer.   
 
2.4.2. Molecular geometry determines minimum-energy structure 
The critical packing parameter v/(aolc) determines the minimum-energy structure of an 
aggregate of amphiphiles, where v is the chain volume, lc is the critical chain length beyond 
which an extended hydrocarbon chain would not be in the fluid state, and ao is the optimum 
headgroup area. Table 2 summarizes the packing parameter values corresponding to common 
aggregate structures.  
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3
1<
cola
v   
 spherical micelles 
2
1
3
1 <<
cola
v    
 non-spherical micelles 
1
1
2
1 <<
cola
v    
 vesicles or bilayers 
1<
cola
v       
 inverted structures 
Table 2. Aggregate structures determined by different packing parameters for amphiphilic molecules. 
Modified from Israelachvili, Intermolecular and Surface Forces, 1992. 
 
 v and lc can be calculated from the hydrocarbon chain length as indicated in Equations 
10 and 11, while ao is usually measured experimentally and may change with pH and 
temperature depending on the headgroup. 
 
310)9.264.27( −×+≈ nv  
Equation 10. Volume (in nm3) of an n-carbon chain. 
 
nllc 1265.0154.0max +≈≤  
Equation 11. Length (in nm) of an n-carbon chain. 
 
The number of carbons is given by n, and lmax is the maximum extended chain length (in the 
crystalline state). lmax and lc are in nm. For a molecule with multiple chains, the total v is found 
by summing the volumes of all chains.  
Aggregates with headgroup area a < ao are energetically unfavored; this geometric consideration 
yields the critical radius given in Equation 12. 
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Equation 12. Optimal radius of a bilayer vesicle.  
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 DPPC has an ao of 52.3 Å2/molecule  at 25ºC [20]. Each of its 16-carbon chains has a 
volume of 457.8 Å3 and a length of 21.78 Å. The critical packing parameter is therefore between 
0.5 and 1, indicating that vesicles or flexible bilayers are the minimum-energy structure of DPPC 
aggregates in aqueous solution. 
 
   804.0
78.21*3.52
)8.457(2 ==
cola
v  
 
The packing parameter explains the relative reluctance of DPPC to adsorb to the air-
water interface, a tendency that can be overcome by mixing DPPC with more cylindrical 
molecules such as hexadecanol or palmitic acid. These molecules have been shown to decrease 
the molecular tilt in monolayers of DPPC [38] and DPPC/POPG [39] at the air-water interface. 
Indeed, the packing parameter of palmitic acid shows that its minimum-energy aggregate 
structure would be a planar bilayer. Palmitic acid has a monolayer ao of about 20 Å, and a 16-
carbon chain identical to that of hexadecanol. 
 
06.1
78.21*20
8.457 ==
cola
v      
 
 
Exosurf, patented in 1989, utilizes hexadecanol to improve the adsorption of DPPC [40], 
and tyloxapol. A mixture of DPPC and hexadecanol also functions as a replacement lung 
surfactant[9]. An alternative synthetic RLS consists of DPPC, cholesterol, and 
dioleoylphosphatidylethanolamine, which forms inverted structures where the hydrocarbon tails 
of the lipid molecules face outwards. The composition of this mixture is such that it undergoes a 
transition from a disordered phase to an inverted phase near mammalian physiological 
temperature [41]. It was thought that the inverted structures, being hydrophobic, would adsorb to 
the air-water interface more rapidly than their vesicular counterparts.   
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2.5.Exosurf 
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signi    2.5.1. Background and clinical trials
 Exosurf (GlaxoSmithKline) is a solution in 0.1 M NaCl of approximately 84% DPPC, 
D, 6% TY [40]; that is, 13500 ppm DPPC, 1500 ppm HD, and 1000 ppm TY. It is available 
linical use in the United States as a dry lyophilized powder, stored under vacuum, to be 
stituted with sterile water. Exosurf was intended as a purely synthetic, easy-to-store 
native to naturally-derived surfactants. It is moderately effective in treating NRDS in 
aturely born animals [40] and humans [10].  
Exosurf is prepared by dissolving powdered DPPC and HD in a solution of tyloxapol and 
 NaCl, gently rotating the sample vials for two hours at 60ºC,  dividing into 8-mL aliquots, 
ing to -70 degrees Celsius, and removing the water by lyophilization over 24-30 hours to a 
 pressure of 10 mmHg. Before use, distilled water is added to the resulting powder, which 
taneously disperses, and the contents are drawn into a syringe [40]. This process likely 
uces large multilamellar vesicles [36]. 
Early clinical trials of Exosurf in ARDS showed improvements in mortality and lung 
liance[42], and oxygenation[43], relative to a saline control. However, the use of  Exosurf 
 ARDS treatment has been suspended since a 1995 trial with human infants showed no 
ficant improvement over the control [44]. 
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Figure 8. Components of Exosurf, dissolved in 0.1 M NaCl for clinical use. The polyethylene oxide headgroup 
of Tyloxapol is highlighted. The figure of DPPC is reprinted with permission from Avanti Polar Lipids, Inc.  
(www.avantilipids.com). The figure of Tyloxapol is reprinted with permission from Sigma-Aldrich Company. 
(www.sigma-aldrich.com) 
 
            2.5.2. Components 
 
The structures of Exosurf’s components are shown in Figure 8. 
Dipalmitolyphosphatidylcholine (DPPC) is an essential component in all lung surfactants (LS) 
for achieving low surface tension, but does not function as an RLS on its own due to its slow 
adsorption; a 5 mg/mL solution reaches an equilibrium surface tension of 66 mg/mL after 10 
seconds adsorption, compared to natural LS [27] . 
Hexadecanol (HD) is also intended to maintain low surface tensions and help material to 
remain at the interface for repeated compression cycles [40]. Mixing HD or PA into a solution of 
DPPC, spread at the air-water interface, produces a monolayer with a greater area fraction of 
solid phase at a given surface pressure compared to a monolayer without HD. [38]. This will be 
explained further in Section 3.  
Tyloxapol (TY), also sold as Triton WR-1339, can be considered a polymer of the 
synthetic surfactant Triton X-100, with a maximum of 7 surfactant monomers per molecule and 
an ethylene oxide chain length of 8-10[45].  TY increases the solution’s shelf life and enhances 
dissolution of the powdered components [40]. 
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 TY is also thought to confer a small amount of inhibition resistance. Cheng and Chang 
demonstrated that adding greater than 10 ppm TY to 1000 ppm DPPC in a pulsating bubble 
surfactometer reversed the 20 mN/m rise in equilibrium surface tension (γe ) & minimum surface 
tension (γmin) caused by 10-100 ppm bovine albumin. However, at lower TY concentrations the 
surface tension of the solution was closer to that of the albumin solution. High TY concentrations 
raised the minimum surface tension of the mixture above that of the DPPC-only solution [46].  
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3. METHODS  
3.1.Langmuir trough 
3.1.1. History 
Agnes Pockels, a self-taught researcher with only a girls’ high school education, invented 
the first Langmuir trough in her kitchen after reading a paper by Lord Rayleigh on finding the 
molecular area of surface active molecules. She used her device to measure the minimum 
interfacial area required for an oil film on a water surface. This point became known as the 
“Pockels point”, now called the limiting molecular area.  In 1881 she communicated her results 
to Rayleigh, who facilitated publication of her work in the journal Nature [47]. In 1917 Dr. 
Irving Langmuir used an improved version of her method to determine a Pockels point of 21 Å 
for fatty acid monolayers on a water surface [48].  His work achieved much wider recognition 
than Pockels’, with the result that the instrument she invented became known as the Langmuir 
trough. 
3.1.2. Measurement of surface pressure 
Surface pressure (π) is the force per unit length exerted by the spreading of an 
amphiphilic molecule on an aqueous surface. This concept can be vividly illustrated by 
depositing a detergent droplet on a water surface and watching the movement of a paper boat[49] 
[50] across the surface away from the deposition site. Surface pressure is defined by the relation 
π = γo – γ
Equation 13. Relationship between surface tension and surface pressure. 
 
where γo represents the surface tension of the pure subphase, and γ represents the surface tension 
of the monolayer atop the subphase.  
The “improved” film balance utilized by Langmuir [48] measured surface pressure as a 
horizontally-applied force. The surface pressure was calculated from the smallest weight, 
attached to a waxed-paper barrier, required to keep the barrier from moving across the water 
surface with the spreading of the monolayer. The rectangular trough had a surface area of 2-3 
square feet. An attached ruler permitted the calculation of the area per molecule.   
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 Modern troughs typically use a Wilhelmy plate to measure surface pressure. The 
Wilhelmy plate consists of a filter paper or platinum strip, suspended from an electronic 
microbalance, whose edge is submerged in the liquid. The surface tension and the plate’s weight 
both exert downward forces on the microbalance, while the buoyant force (due to the submerged 
portion of the plate) exerts an upward force. This can be represented by Equation 14:  
( ) ( ) ( ) ϕγρρ cos2 twghwtglwtF Lp ++−=
 
Equation 14.  Force on a Wilhelmy plate = plate weight – buoyant force + surface tension 
 
where ρp is the plate’s density, ρL is the liquid’s density, γ is the surface tension, ϕ is the contact 
angle between the liquid and the plate, g is the acceleration due to gravity, and  l, h, w, and t are 
respectively the length, submerged height, width, and thickness of the plate. The weight and 
buoyant force contributions are neglected because the initial pressure measurement is set to zero. 
When the plate is completely wetted by the liquid, the liquid-plate contact angle becomes zero. 
Equation 14 therefore reduces to Equation 15; the surface tension is calculated from the plate’s 
weight & thickness, and the total force F on the microbalance [51].  Surface tension is then 
converted to surface pressure using Equation 13. 
 ( )γtwF += 2
 
Equation 15. Force on a Wilhelmy plate that is completely wet by the liquid, where the pressure 
sensor is set to zero so that the weight and buoyant force on the plate can be neglected.  
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3.1.3. Modern trough design 
 
 
Figure 9. Cartoon of a Langmuir trough with confined area for surfactant (well), barriers and 
surface tensiometer labeled 1, 2 and 3 respectively. 
 
There are currently several commercially available Langmuir troughs. Manufacturers 
include NIMA Technologies, Kibron, and KSV.  The cartoon in Figure 9 demonstrates the 
essential features:  (1) a well made of an inert material to hold the surfactant film and water or 
other subphase (2)  a motorized, movable barrier to compress the surface film while permitting 
the subphase to remain evenly distributed in the well (3)  a surface tension measuring device 
(tensiometer).  Not shown is the computer with software and hardware required to control the 
barrier motors, maintain a fixed trough temperature, and convert the electronic signals of the 
barrier motors and surface tensiometer into the isotherm exemplified in Figure 10. For a single 
species of surfactant of known molecular weight, or for a surfactant mixture with a calculated 
number average molecular weight, an isotherm indicates the average area occupied per molecule 
at each surface pressure.    
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3.1.4. Isotherms: effect of temperature 
 
 
Figure 10. (a) Isotherms of DPPG at different temperatures. X : 34ºC  ∆: 30ºC □ : 26ºC ◊ : 22ºC.  Reprinted 
with permission from Vollhardt, J. Phys. Chem. B., 2000. Copyright (2000) American Chemical Society.  
(b) Structure of DPPG, reprinted with permission from Avanti Polar Lipids, Inc. (www.avantilipids.com) 
 
Pressure-area isotherms, which are plots of surface pressure versus area, are a standard 
method of characterizing surfactant phase behavior. Figure 10 shows a pressure-area isotherm 
for dipalmitoylphosphatidylglycerol (DPPG), a lipid component of LS [52]. As the surface area 
is reduced, the monolayer undergoes a transition from the low-density gas phase to a higher 
density fluid phase. This is analogous to the gas-liquid phase transition that occurs when the 
volume of a three-dimensional gas sample is reduced at constant temperature. Once the sample is 
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 completely in the fluid phase, the pressure rises from zero as the monolayer is further 
compressed. A sudden change in slope is observed, in Figure 10 at 10 mN/m pressure for the 
34°C sample, as crystallites of a condensed phase begin to form; these crystallites are in 
equilibrium with the surrounding fluid phase. The transition to nearly vertical slope at high 
compression forms a completely condensed monolayer. One or more condensed phases may 
exist, distinguished by differences in molecular tilt angle relative to the surface normal; finally, 
various solid-crystalline phases may exist, with vertical molecular tilt (not shown) [24]. Phase 
transitions are characterized by changes in the slope of the isotherm; however, an isotherm alone 
is not sufficient to determine the molecular tilt in a monolayer. 
The monolayer exhibits a “critical temperature”, Tc , below which the liquid phase does 
not exist and the monolayer transitions directly from the gaseous to the condensed phase upon 
compression. This is evident in the disappearance of the gas-fluid transition in isotherms taken 
below Tc. A limiting molecular area of approximately 0.4 nm2/molecule, or 40 Å2/molecule, 
corresponds to the area required for two hydrocarbon chains, which occupy around 20 Å2 each. 
The packing profile of the monolayer molecules determines the exact nature of the 
transitions; for example, a cylindrical molecule may form a highly ordered solid crystalline phase 
at high compression, while a more irregularly shaped molecule may only form less-ordered 
condensed phases. DPPG is an example of a molecule that forms a condensed phase rather than a 
solid crystalline phase; its large headgroup area compared to the area occupied by its 
hydrocarbon chains prevents it from packing as tightly as a cylindrical molecule such as 
hexadecanol. 
Isotherms are also used to evaluate molecular interactions; for instance, the surface 
pressure at which a dissolved protein can insert into an established film compared to the pure 
protein’s equilibrium spreading pressure indicates the strength of attraction between a particular 
surfactant and protein [53].   
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3.1.5. Isotherms: effect of composition 
 
 
Figure 11. Spread monolayers of DPPC:HD in ratios (a’)  3:1, (b’) 1:1, and (c’) 1:2, plus 0.5 mol% BODIPY 
FL C12 (fluorescent probe). Isotherms were recorded on a water subphase at 30ºC. Images were recorded at 
surface pressure of 15 mN/m (horizontal dashed line). Reprinted with permission from Lee et al, J. Chem. 
Phys. 2002. Copyright (2002) American Institute of Physics. 
 
Lee and coworkers [38], using the Langmuir trough in conjunction with fluorescence 
microscopy, found that addition of cylindrical molecules to monolayers of more conical 
molecules raises the critical temperature Tc , a characteristic of the monolayer, at which the gas-
fluid transition takes place. The effect on the monolayer fluidity at given surface pressure is 
analogous to lowering the monolayer’s temperature. 
DPPC was mixed with hexadecanol (HD) in chloroform solution, in DPPC:HD molar 
ratios of 3:1, 1:1, 1:2, and 1:4. The lipid-analog fluorescent probe BODIPY FL C12 (4-4-difluoro-
5,7-dimethyl-4-bora-3a,4a,diaza-s-indacene-3-dodecanoic acid) was added at 0.5 mol%; this 
probe preferentially locates in the fluid phase and is excluded from condensed crystallites, 
allowing the fluid phase to appear bright and the condensed phases to appear dark in the 
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 fluorescence images. The mixtures were deposited dropwise on a water subphase at 30°C, and 
the solvent was allowed to evaporate before compression of the monolayer at a rate of 0.1 
mm/sec.  
The isotherms and images are presented in Figure 11, where the x-axis is defined in 
terms of molecular area per hydrocarbon chain. DPPC contributes two chains, and HD 
contributes one chain.  At 15-16 mN/m, pure DPPC undergoes a first-order phase transition from 
a fluid phase to a condensed phase, indicated by an abrupt decrease in the isotherm’s slope. A 
second-order transition, from a tilted condensed phase to an untilted condensed phase [54], 
occurs at 20 mN/m. Mixtures of 1:2 and 1:4 DPPC:HD, and pure HD monolayers, appear to 
transition directly from the gas phase to the untilted condensed phase, indicating that 30ºC is 
below the triple point temperature of these mixtures. The addition of HD thus decreased the 
fluidity of the monolayer, and is equivalent to lowering the monolayer’s temperature.  
The images a’, b’ and c’ in Figure 11 provide additional support to this interpretation of 
the isotherms. Each image was taken at a surface pressure of 15 mN/m. While the bright region 
representing the fluid phase is abundant in Figure 11a’ (3:1 DPPC:HD), it is much less visible in 
Figure 11b’ (1:1 DPPC:HD)  and nearly eliminated in Figure 11c’ (1:2 DPPC:HD), where the 
condensed phase now occupies the entire surface area. The DPPC:HD ratio of 3:1 (Figure 11a’) 
corresponds to the composition of Exosurf, which contains DPPC:HD: Tyloxapol in a molar 
ratio of approximately 75:24:1.  
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3.2.SAXS 
3.2.1. Bragg’s law and X-ray diffraction 
  
 
 
Figure 12. Schematic of diffraction from lipid lamellae.   
 
SAXS is based on Bragg diffraction, where light that scatters from a series of planes 
exhibits constructive interference at angles (θpeak) that are directly proportional to the light’s 
wavelength (λ) and inversely proportional to the spacing (dstructure) between the planes (Equation 
8).  The planes can be oriented so that light is incident from different angles, with each ray’s 
scattering angle equal to its angle of incidence; however, only at the scattering angles satisfying 
Bragg’s law will a diffraction maximum be visible.  
 
peak
structured
n θλ sin
2
=  
Equation 16. Bragg’s law. 
       
The scattering vector, q, which is the vector between the incident & scattered beams, is 
2π/d for any distance d. X-ray diffraction data is usually plotted as intensity versus q, and the 
dstructure characteristic of the system  is calculated from the qpeak at which diffraction maxima are 
located. Bragg’s law can be rewritten in terms of q as shown below. The relationship between the 
positions of the first-order, second-order and third-order maxima can identify the type of 
structure. A lamellar structure produces maxima whose positions are integer multiples of the 
first-order peak position. 
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Equation 17. Relationship between qpeak , dstructure, and θpeak. 
 
The diffraction signal is proportional to source intensity, degree of order, and the 
difference in electron density between the sample and surrounding medium. In some cases, 
experimental conditions require the use of synchrotron X-radiation, whose high intensity aids in 
the characterization of highly disordered or low-contrast samples. Fortunately, the high degree of 
order in the lipid lamellar system under study allows us to use a lower intensity source, a rotating 
anode. 
Multilamellar vesicles are considered powder samples, which consist of randomly 
oriented crystallites but are not necessarily dry or “powdery”. Each crystallite projects onto the 
detector a pattern of diffraction spots that is oriented in a slightly different direction than the 
pattern from other randomly oriented crystallites. These patterns all combine to produce a series 
of concentric circles with diameter 2θpeak. , related to dstructure according to Bragg’s law 
(Equation 16),  where 2θpeak is in radians. Sample diffraction patterns from lipid lamellae are 
shown in Figure 13.  
 
 
Figure 13. Examples of diffraction patterns from multilamellar lipid vesicles. 
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3.2.2. SAXS data collection.   
 
 
Figure 14. The Bruker Nanostar in SAXS configuration.  
 
The scattering from copper Kα radiation (wavelength 1.54 angstroms) at room 
temperature under ~ 0.2 torr vacuum was collected from the samples via a Bruker Nanostar small 
angle x-ray scattering (SAXS) diffractometer, run at 40 kV and 60 mA and mounted on a 6 kW 
rotating anode. 
The Nanostar utilized cross-coupled Gobel mirrors to create a highly parallel beam of 
copper Kα radiation which was further refined by a .1 mm pinhole approximately 3 inches 
downstream from the exit aperture of the Gobel mirrors; just before the sample, a .3 mm pinhole 
trapped scattering created by the .1 mm pinhole.   Scattered radiation from the sample and optics 
was collected by a Bruker HiStar 2D detector placed approximately 65.4 cm downstream from 
the sample position; just before the detector face, a beamstop approximately 3 mm in diameter 
absorbed the direct beam.  To minimize air-scattering, the entire flightpath between the .1 mm 
pinhole and the HiStar was held under vacuum in the Nanostar’s Anton-Paar Pinhole Chamber.    
All samples were loaded and flame-sealed into 1 mm quartz capillaries (Charles Supper 
Company, Natick, Mass., Cat # 10-QZ).  All SAXS experiments were performed at ambient 
temperature, which varied between 70 and 80 degrees Fahrenheit.    Exposure times ranged from 
15 minutes to 4 hours.  
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 Intensity of scattering was recorded as average counts/pixel, and background scattering 
from the quartz capillary was subtracted according to Equation 19. The attenuation factor τs is 
obtained with the glassy carbon between the sample and the beam, where “qtz” denotes the 
empty capillary and “GC” denotes the glassy carbon (Equation 18). Itotal(2θ) and Iqtz(2θ) are 
intensity values from the measured diffraction patterns (recorded without the glassy carbon) of 
the sample capillary and  empty capillary, respectively. The attenuation factor expresses how 
much the sample reduces the beam intensity incident on the quartz capillary walls. Multiplying τs 
by Iqtz(2θ) yields the light intensity scattered from the capillary after passing through the sample. 
Subtracting this quantity from Itotal(2θ) yields the light intensity scattered from the sample alone.  
 
( )
GCqtz
GCqtzsample
s I
I
+
++=τ  
 
Equation 18. Attenuation factor, recorded with glassy carbon. 
 
( ) ( ) ( )θτθθ 222 qtzstotalsample III −=  
 
Equation 19. Background-subtracted sample intensity.  
       
Factors contributing to the scattered intensity include the amount of order in the sample, 
and the contrast in electron density between the sample and its surroundings. A highly ordered 
sample produces a stronger scattering signal than a more disordered sample. 
  See Appendix for further details on SAXS data collection and analysis. 
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4. EXPERIMENTAL PROTOCOLS 
4.1. Materials 
All materials were used without further purification unless otherwise indicated. 
DPPC: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine was obtained in powder form from Avanti 
Polar Lipids (Alabaster, AL) 
NaCl; Sodium chloride was obtained from Mallinckrodt (Phillipsburg, NJ). 
NaAz: Sodium azide was obtained from Alfa Aesar (Ward Hill, MA). 
CHCl3 : Chloroform was obtained from Fisher.  
NBD-PE: N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl –sn-glycero-3-
phosphoethanolamine, triethylammonium salt was obtained from Molecular Probes, Inc. 
DI H2O: Deionized water (18.2 MΩ-cm, TOC ~ 6 ppb) was used for all aqueous solutions. 
Dialysis tubing: 8000 Dalton MWCO, 4mm flat width, regenerated cellulose tubing was 
obtained from Spectrum Laboratories, Inc. (Rancho Dominguez, CA) and soaked in 0.1 M NaCl 
for at least 30 minutes before use.  
Capillaries: 1 mm diameter quartz capillaries were obtained from the Charles Supper Co.  
 
The following were obtained from Sigma-Aldrich Company:  
HD: Hexadecanol 
TY: Tyloxapol  
PEG10K: Polyethylene glycol, avg. m.w. 10,000 
PEG20K: Polyethylene glycol, avg. m.w. 20,000 
BSA: Bovine serum albumin 
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4.2. Exosurf monolayers 
4.2.1. Without PEG 
 
The Exosurf and DPPC samples in this study were originally intended for imaging. A 
fluorescently tagged lipid (NBD-PE) was added to the solution at 0.5 mol% relative to the 
concentration of DPPC; that is, the solution contained 0.05 moles of NBD-PE for every 99.5 
moles of DPPC. 
An Exosurf + NBD-PE solution was prepared at a concentration of 1 mg DPPC/mL in 
CHCl3. 5 mL of this solution contained 4.97 mg DPPC, 0.54 mg HD, 0.36 mg TY, and 0.03 mg 
NBD-PE. It was stored at -20ºC and protected from light when in use. 
A DPPC + NBD-PE solution containing 0.5 mol% NBD-PE in 1 mg/mL total lipids was 
prepared at a concentration of 1 mg/mL total lipids in CHCl3. 5 mL of this solution contained 
4.97 mg DPPC and 0.03 mg NBD-PE. It was stored at -20ºC and protected from light when in 
use. 
The Langmuir trough for these experiments was a KSV Minitrough (KSV Instruments 
Inc. Finland), whose effective surface area is 18750 mm2. The trough was equipped with 
hydrophilic barriers and filled to just below the rim with 160 mL of the subphase solution, which 
was then brought to 24.5ºC before deposition of the monolayer.  
The lipid solutions were thawed by sonication at room temperature and deposited 
dropwise on the surface. The solvent was allowed to evaporate for 10 minutes before 
compression of the trough barriers. Surface pressure was measured with a Wilhelmy plate. 
Unless otherwise indicated, all compressions and expansions occurred at a rate of 7.5 
cm2/minute, and the buffer was pH 7.2-7.4, 150 mM NaCl, 1.5 mM CaCl2, 5 mM tris-HCl. 
 
4.2.2. With PEG 
 
The surface pressure was set to zero at a known volume of PEG-free buffer at 24.5ºC. 
The buffer was then removed, and the trough was filled with the same volume of 5% PEG10K in 
buffer. The monolayer was deposited onto the PEG solution and the solvent evaporated for 10 
minutes before commencing repeated compressions of the solution.  
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 4.2.3. With bovine serum albumin 
 
An Exosurf monolayer was compressed on buffer at 24.5ºC and held at 50 mN/m while BSA 
in buffer was injected to a final concentration of 2 mg/mL and gently mixed into the subphase. 
The barriers were re-expanded at a rate of 7.5 cm2/minute, and held open for 1.1 hour while BSA 
adsorbed to equilibrium. The barriers were then re-compressed. 
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4.3.SAXS sample preparation 
4-mL glass vials with Teflon-lined caps were cleaned with detergent, etched with 
KOH/isopropanol for at least 10 minutes, rinsed with DI H2O and dried under vacuum while 
heating. 
0.1 M NaCl in DI H2O was prepared, without adjusting pH.   
Chloroform stock solutions of 350 mg/mL DPPC, 53 mg/mL HD, and 49 mg/mL TY 
were prepared. High concentrations were necessary in order to minimize the volume of 
chloroform to be evaporated. 
For a 300-mg sample of Exosurf, in which the total lipid mass (20% of the sample mass) 
is 60 mg, 147 µL DPPC stock was mixed with 102 µL HD stock and 73.5 µL TY stock. An 
alternative preparation method consisted of combining larger volumes to make a solution of 
Exosurf in chloroform, and pipetting a known volume of this solution into each vial.  
The chloroform was evaporated by a stream of filtered air blown over the sample as the 
vial was tilted and slowly rotated to coat the side of the vial with a thin layer of solution. 
Samples initially appeared clear and colorless, gradually increasing in viscosity and opacity.  
 The resulting white powdery mixture was stored at 4ºC overnight, resuspended in excess 
0.1 M NaCl to a final lipid concentration of 20% by vortexing, and sonication while heating 
above the melting temperature of hexadecanol (47º-50ºC), using a centrifuge as necessary to 
collect material at the bottom of the vial. If the vial was not tilted but instead left stationary 
during the drying process, the layer of dried solid coating the vial was thicker and more difficult 
to reconstitute. 
The control for this experiment was 20% by weight of DPPC in 0.1 M NaCl.  
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4.3.1. Osmotic stress applied with dialysis membrane 
 
Equilibration solutions containing polymer in 0.1 M NaCl were prepared. The solution 
compositions are given below by polymer weight percentage in 0.1 M NaCl.  
 
PEG10K: 1%, 2%, 5%, 10%, 20%, 32%, and 40%  
 
The following equilibration solutions were prepared in 0.1 M NaCl plus 0.1% NaAz as a 
bactericidal agent:  
 
Dextran 150K: 16%, 22%, 31%, 37% 
 
These were added in excess directly to the maximally-hydrated Exosurf or DPPC 
(approx. 1 mL of PEG10K solution for each 300-mg sample). The samples were then 
homogenized by vortex, heat and sonication until no visible chunks remained. Samples were 
stored at 2º- 8ºC for at least 24 hours. To ensure that the system was truly at equilibrium, the 
solution was changed at least twice. This process consisted of centrifuging the sample to pellet 
and replacing the supernatant with fresh solution.  
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4.3.2. Osmotic stress applied with dialysis membrane 
 
Solutions of PEG20K in 0.1 M NaCl, 0.1% NaAz with polymer weight fractions 5%, 
20%, 30%, 35%, and 40% were prepared. 
The control sample consisted of 10-30 µL Exosurf in excess 0.1M NaCl + 0.1% NaAz, 
sealed in a 1.0 mm diameter quartz capillary. 
Dialysis tubing was soaked in 0.1 M NaCl for 30 minutes prior to use. 
 
Curosurf solutions were prepared in a similar fashion, with 150 mM NaCl + 0.1% NaAz, pH 7.2-
7.4 buffer as the hydrating solution.  
 
The 0.1% NaAz was added as a preservative, after it had been determined that NaAz did 
not change the peak position of Curosurf samples. NaAz was incorporated into the Exosurf 
samples as follows: Excess 0.1 M NaCl, 0.1% NaAz solution was added to an approximately 
300-mg sample of Exosurf + XS 0.1 M NaCl and vortexed to mix. After centrifuging the sample, 
the supernatant was discarded and replaced with 0.1 M NaCl + 0.1% NaAz.  
 
200-400 µL of the hydrated surfactant were sealed in dialysis tubing and submerged in 
the PEG20K solutions. Samples were dialyzed for 3-10 days before the PEG20K solution was 
replaced. Dialysis was continued for an additional three days, after which surfactant was 
removed and sealed in 1.0 mm diameter quartz capillaries. 
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4.3.3. Mixing albumin with Exosurf 
 
Solutions of BSA, 100 mg/mL and 1 mg/mL in 0.1 M NaCl, were prepared. Exosurf in 
0.1 M NaCl was mixed with BSA to final BSA concentrations of 0.1 mg/mL, 10 mg/mL, and 50 
mg/mL using either of the following procedures. The difference in procedure produced no 
difference in d-spacing.  
 
(1) Repeated cycles of inversion and centrifuge applied to a sealed quartz 
capillary containing aliquots of Exosurf and BSA in 0.1 M NaCl. 
(2) Aspiration of Exosurf solution and then BSA solution into a syringe, without 
emptying the syringe between solutions, followed by repeated expulsion and 
intake of the syringe contents in a quartz capillary (pipetting the solution up 
and down).  
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4.4.Calculation of osmotic pressure 
4.4.1. Range of applied pressures 
 
The BSA solutions exerted pressures of 3.5 x 101 dyne/cm2 (0.1 mg/mL BSA) and 3.6 x 103 
dyne/cm2 (10 mg/mL BSA). The polymer solutions exerted pressures between 105 and 107 
dynes/cm2 . Values for the pressure were calculated or obtained from literature as described 
below. 
 
4.4.2. Osmotic pressure from PEG and Dextran 
 
In order for a solute to exert osmotic stress on a multilamellar aggregate M, there must be 
a region around M where the concentration of solute molecules is greater or less than their 
concentration in the bulk [19]. Since this is not the case with NaCl and NaAz, which freely move 
around M, the PEG or albumin was considered the only osmolyte.  
The samples with PEG20K were equilibrated at 4-8ºC and those with PEG10K were 
equilibrated at room temperature. Rand and coworkers provide data for the osmotic pressure 
exerted by PEG20K at 7ºC, PEG10K at 30ºC, and Dextran 150K at 20ºC [55]. The following 
equations fit these data, where P is in dynes/cm2, and were used to calculate the osmotic stress 
exerted by specific weight percentages of polymer.  
 
log [P(wP10K, 30ºC)] = 4.99 + 0.29w0.60      
log[P(wP20K, 7ºC)] = 3.884+1.062w0.343     
log[P(wD150K, 20ºC)] = 1.385+2.185w0.2436 for w < 10%   
log[P(wD150K, 20ºC)] = 1.872+1.657w0.3048  for w > 10%   
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 Lis [56] derived an expression for the change in DPPC bilayer separation (dtotal ) in 
response to osmotic stress P (Equation 20), where dtotal  in angstroms is equal to the DPPC 
bilayer thickness (dlipid) plus the thickness of the water layer (dwater). 
       waterlipidtotal ddd +=
 where 
dlipid = 44.2 Å at 25ºC in water 
⎟⎠
⎞⎜⎝
⎛−= 83.910ln0.2
Pdwater  
Equation 20. Water spacing between DPPC bilayers decreases with increased pressure. 
 
These data are often plotted with P on the y-axis. Substituting for dlipid and dwater, and 
rearranging Equation 20, gives Equation 21 for osmotic pressure in terms of d-spacing for 
DPPC.  
 
⎟⎠
⎞⎜⎝
⎛
−
−
= 2
2.44
83.910
totald
eP  
 
Equation 21. Relationship between P and dtotal for DPPC. From Ref [55]. 
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4.4.3. Osmotic pressure from albumin 
 
The osmotic pressure applied by albumin may be calculated for low concentrations using 
the van’t Hoff law, which is analogous to the ideal gas law.  
 
[ ]RTBP =  
Equation 22. The van’t Hoff law for calculation of osmotic pressure P. 
       
[B] is the molar concentration of a non-dissociating solute, R is the universal gas constant, and T 
is the temperature in degrees Kelvin.  Using this equation, the pressure exerted by 50 mg/mL 
bovine serum albumin (m.w. approx 69,000 g/mol) can be calculated as follows:  
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 Human serum albumin has a similar molecular weight, and is present at similar concentrations 
in the blood.  
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5. RESULTS / DISCUSSION 
5.1.Langmuir trough 
5.1.1.  Isotherms 
 
Figure 15. (a) Exosurf + 0.25 mol% NBD-PE (b) DPPC + 0.25 mol% NBD-PE.  
Samples spread from CHCl3 solution on buffer, and compressed twice in a Langmuir trough at 24.5ºC. Buffer 
is 150 mM NaCl, 1.5 mM CaCl2, 5 mM tris-HCl, pH 7.25.   
 
 
 The results are presented in terms of trough area percent, since the molecular weight of 
tyloxapol is not precisely known. This molecular weight is, however, estimated to be 4.5 kDa, or 
4500 g/mol [57]. Using this estimate, the average molecular weight of Exosurf is 650 g/mol, with 
a molar ratio of 75:24:1 DPPC:HD:TY. The molar ratio of DPPC to HD in Exosurf is therefore 
approximately 3:1, and this isotherm can be compared to the 3:1 DPPC:HD isotherm in Figure 
11.   
The elimination of the fluid-condensed transition seen in pure DPPC (Figure 15) at 10 
mN/m at 24.5ºC, can be interpreted as a reduction in monolayer fluidity caused by the addition 
of cylindrical HD molecules, and is consistent with Lee’s results [38].  Howver, the phase 
transition seen in Exosurf at 40 mN/m (Figure 15) does not appear in the 3:1 DPPC/HD 
isotherm, or in the pure DPPC isotherm, of Figure 11. In the Exosurf isotherm taken on PEG –
containing buffer (Figure 16), this transition becomes less prominent upon repeated 
compression. The transition vanishes from the Exosurf isotherm in Figure 17 after a single 
compression and addition of bovine serum albumin (solid blue and dotted red lines).  
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Figure 16. Repeated compressions of Exosurf spread from chloroform on buffer containing 5 wt% PEG 10K 
at 24.5ºC. Solid line: First two compressions. Dashed line: Second two compressions. Each compression or 
expansion takes 8.3 min at a compression rate of 7.5 cm2/ min.  Buffer is 150 mM NaCl, 1.5 mM CaCl2, 5 mM 
tris-HCl, pH 7.25. 
   
 
Figure 17. Exosurf + 0.25% NBD-PE compressed on buffer without PEG at 25 C. Bovine serum albumin was 
injected after compression to a concentration of 2 mg/mL, the barriers were re-expanded, and the albumin 
was allowed to adsorb. Upon re-compression, the fluid-condensed transition vanishes from the Exosurf 
isotherm, indicating a change in monolayer composition. Buffer is 150 mM NaCl, 1.5 mM CaCl2, 5 mM tris-
HCl, pH 7.25.   
 
44 
 A reduction in the slope of an isotherm indicates that surface pressure changes less 
dramatically with reduction in area. This could indicate the growth of condensed-phase domains 
in an overall fluid phase, or the collapse of a monolayer component; that is, the formation of 
surface-associated vesicles, folds, or multilayers that are then lost to the subphase. For example, 
in Figure 3 (reproduced here as Figure 18), the plateau at 70 mN/m corresponds to the 
formation of surface-associated material that is visible as bright streaks (Figure 18B) in the 
fluorescence images. The loss of material to the subphase is evident in the hysteresis upon the 
second compression, which does not typically occur when a monolayer is re-expanded before 
collapse (compare to the DPPC isotherm in Figure 15 ).    
 
 
Figure 18. DPPC/POPG/PA 69/21/10 wt% on 25 °C 150 mM NaCl, 2 mM CaCl2, 0.2 mM NaHCO3 , pH 7, 
0.5-1 mol% TR-DHPE added for imaging. Images were taken at the surface pressures indicated by the 
corresponding letters.  Bright streaks indicate collapsed material. Reprinted with permission from Warriner 
et al, Biophys. J. 2002. Copyright (2002) Biophysical Society. 
 
 
Schurch [29] first advanced the argument that Tyloxapol must be squeezed out in order 
for Exosurf to attain minimum surface tensions. Further consideration of Tyloxapol’s solubility 
in water (Section 5.1.2) and the hysteresis evident upon repeated compression of the Exosurf 
monolayer on 5% PEG10K, indicates that the transition at 40 mN/m in Figures 15, 16 and 17 
may result from the collapse of Tyloxapol and its subsequent loss into the subphase. If this is the 
case, the rapid removal of the transition on the albumin-containing buffer may depend on the 
relative concentrations of tyloxapol and albumin. The adsorption of Tyloxapol has been shown to 
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 dominate the surface tension of an albumin-tyloxapol mixture; however, this effect only occurs 
at high tyloxapol concentrations [46].  In our model of ARDS, the subphase concentration of 
tyloxapol resulting from its removal at high pressures was not high enough for the collapsed 
tyloxapol to effectively compete with the adsorption of albumin.  In contrast, the isotherm of 
Exosurf spread directly on an albumin-containing subphase (dotted purple line in Figure 17) 
initially exhibits the surface tension of albumin solution, but at higher compressions it displays a 
phase transition similar to that observed in Exosurf on albumin-free buffer. In this case, 
tyloxapol is likely present at the surface in addition to albumin, DPPC, and HD. 
Further work is necessary to determine whether the isotherm on PEG-free buffer exhibits 
similar hysteresis compared to the isotherm on the 5% PEG10K subphase. Faster elimination of 
the phase transition in the 5% PEG10K case may provide evidence towards a tyloxapol-PEG 
interaction. 
A fluorescence image of the Exosurf monolayer could reveal whether the bulky structure of 
Tyloxapol disrupts the packing of the DPPC/HD monolayer, allowing it to remain more fluid at 
given surface pressures. At 15 mN/m the monolayer should display a greater percentage of fluid 
phase compared to the 3:1 DPPC:HD imaged in Figure 11a’.  
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5.1.2. Tyloxapol solubility supports results 
 
A spread monolayer at constant pressure is gradually depleted by motion between 
monolayer and subphase, so that at time t the trough area A may differ from the original surface 
area A0 as shown in Equation 23. 
ktoeAA −=  
Equation 23. Reduction in trough area over time for a spread monolayer at constant pressure. 
 
This motion can be viewed as diffusion through a thin layer of solution with thickness δ 
so that the rate constant k can be determined by differentiating Equation 23 and using Fick’s 
law[24], where n is the number of moles of amphiphilic molecules. In Equation 26 defining the 
rate constant, D is the diffusion coefficient and Cf is the equilibrium concentration immediately 
underneath the monolayer. The bulk concentration C is considered to be zero for initial rates of 
diffusion. Γ is the number of molecules per unit area.   
 
 
Equation 24. Fick’s law applied to diffusion through a layer of solution with thickness δ. 
 
( )
K
DCCDk f δδ =Γ
−=  
 
where 
fC
K Γ=  
Equation 25. Rate constant for the dissolution of a spread monolayer. 
 
 The solubility of stearic acid, a typical monolayer component, is 3 mg/L or 0.003 mg/mL. 
Tyloxapol is 106 times more water-soluble, with a solubility of 100 mg/mL [57], and should 
therefore dissolve from the interface much faster than the more insoluble DPPC and HD. 
( )CCDn
dx
dCAD
dt
dn
f −Γ−== δ
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 5.2. SAXS 
 
5.2.1. Curosurf 
 
 
Figure 19. Variation in d-spacing with pressure for Curosurf. 
 
Curosurf experiences a 50 Å change in d-spacing over the range of pressures applied (100 
to 108 dyne/cm2), with the data falling on the same curve regardless of whether the Curosurf was 
equilibrated with polymer, albumin or both. The data was fit to an exponential curve with a 
decay constant of 7.22 ± 0.23 Å. The decay constant is proportional to the slope of the log10P 
versus d curve. This indicates the nature of the interlamellar interactions, which determine how 
the system’s d responds to applied P. For example, Equation 21 for DPPC lamellae in a similar 
situation has a decay constant of around 1-2 Å. Neutral lamellae whose interactions involve only 
hydration forces and no electrostatic repulsions  are easier to compress, so the log10P versus d 
curve for DPPC in aqueous solution has a steeper slope. This can be seen in Figure 20, where 
the electrostatic pressure fit for Curosurf is plotted alongside the calculated relationship for 
DPPC.  
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 The decay constant for Curosurf is close to the Debye length of 7.85 Å in 150 mM NaCl 
at 25°C, which suggests that there are electrostatic interactions between the lamellae. This is 
consistent with the composition of Curosurf, which includes a total of 6% negatively charged 
lipids and 1-2% cationic surfactant proteins.  An identical experiment done at 1 M NaCl should 
yield a decay constant of around 3 Å and would lend further support to this hypothesis. 
X-ray reflectivity data [54] shows the protrusion of surfactant protein B (SP-B) about 11-
17 Å from the surface of a fatty acid monolayer. This distance, combined with the 43-47 Å 
estimated thickness of the Curosurf lipid bilayers, produces a minimum spacing of 58 Å that is 
consistent with the limiting d observed in our SAXS data. SP-B may therefore obstruct further 
compression of the lamellae. SP-B could also be responsible for the single phase to multiphase 
transition, as areas of the monolayer that did not contain SP-B could be compressed slightly 
farther than areas of the monolayer with SP-B.  
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5.2.2. Exosurf 
 
 
 Figure 20. Variation of d with pressure for Exosurf.  
 
 Over the range of pressures exerted, Exosurf’s d-spacing (Figure 20) displays no easily 
defined trend. In some cases, data points taken at similar pressures have quite different d-
spacings. Note the 10 Å difference between the pairs of Exosurf + PEG20K samples at around 
105.5 and 106.8 dyne/cm2 , and the 12 Å difference between Exosurf + PEG10K samples at around 
107.3 and 107.6 dyne/cm2 . These differences may indicate separation of the samples into distinct 
phases with different d. 
Consideration of Tyloxapol’s probable structure in the Exosurf membrane indicates that 
Tyloxapol may obstruct compression of the lamellae at the pressures applied. Tyloxapol (TY) 
consists of 7-9 monomers that each contain a 8-10 monomer polyethylene oxide (PEG) 
headgroup. The thickness (L) of the headgroup layer depends on the configuration of the PEG.  
Separation of the monomers by a distance greater than 2Rg would require them to adopt the 
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 mushroom configuration (spread out along the bilayer surface), while a separation less than 2Rg 
would place them in the brush configuration (vertical and rodlike).[35 ] The monomer separation 
in the TY molecule is estimated to be smaller than 2Rg, since the monomers are linked 
immediately adjacent to each other; the headgroups should therefore be in the brush 
configuration. The thickness of a polymer brush layer in a good solvent is given by Equation 26, 
where n is the number of PEG monomers, l is the length of each PEG monomer, and s is the 
mean distance between polymer molecules (in this case, the distance between adjacent TY 
monomers) [58].  
 
3/2
3/5
s
nlLbrush =
Equation 26. Thickness (L) of an adsorbed polymer layer containing n monomers each with length l, 
separated by a distance s. 
 
 Then, given a headgroup length n of 8-10 monomers, an estimated monomer length l of 
3.5 Å, and an estimated separation distance s of 3 Å, the thickness of the TY headgroup layer 
ranges from 31 to 39 Å. Combining this distance with the 43-47 Å thickness of a DPPC bilayer 
yields a possible d range of 74-86 Å for Exosurf, which is offset by about 14 Å from the 59-72 Å 
range that was measured. The smaller measured range may be attributed to some entanglement 
or compression of the TY headgroups that has occurred at the pressures applied. Further 
investigation at low pressures (10-2 to 10-1 dyne/cm2) may reveal the compression of Exosurf 
lamellae from larger d to the apparent limiting d range observed here. The 10 Å variation in the 
data may be attributed to differences in the chain length of the PEG headgroups on Tyloxapol. 
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5.2.3. Conclusions on SAXS data 
 
In order for a solute to exert osmotic stress on a macromolecule (or multilamellar 
aggregate) M, there must be an excess or deficit of solute or water molecules around the 
macromolecule. If the solute or water distribution is not affected by M, then there is no gradient 
in chemical potential that can dehydrate the space between the membranes. Exclusion of solute 
from the macromolecule is caused by solute size and the nature of the solute [19]. The observed 
change in d-spacing with applied pressure on Curosurf vesicles demonstrates that the nonionic 
polymers are excluded from the lamellae and exert depletion forces. This supports the hypothesis 
that nonionic polymers dehydrate LS aggregates, and consistent with Tashiro’s data showing that 
polymer improves the surface activity of Curosurf [16].  
In the case of Exosurf, the data suggests that protrusion of TY headgroups from Exosurf 
bilayers obstructs compression of the lamellae over the pressures applied. Another consequence 
of TY protrusion from Exosurf bilayers is that an aggregate of Exosurf might not experience 
osmotic stress from added polymer, as the polyethylene oxide groups from the tyloxapol could 
freely entangle with the polymer in solution and would not form a depletion layer. The lack of 
definite response to the applied osmotic stress leads us to believe that added polymer at the 
concentrations that were employed here would not improve the surface activity of Exosurf in the 
presence or absence of inhibitors. 
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APPENDICES 
 
I. Protocol for SAXS scans using the Bruker Nanostar 
 
Note: This procedure deals with the use of quartz capillaries; however, alternative sample 
containers include double sided tape or mica windows.    
 
1. Load capillaries (1 mm dia. Quartz).  
a. Place capillary in a test tube padded with Kimwipe. (1/2 kimwipe is usually 
enough) 
b. Put sample into open funnel-shaped end of capillary 
c. Centrifuge until the sample falls down into the closed end. 
i. This should take <15 minutes at higher centrifuge settings (4-6) 
ii. If the sample is very waxy or thick, it may help to roll the sample into a 
narrow cylindrical shape prior to placing it in the capillary. 
d. Turn on torch 
i. Open main valve on oxygen tank. 
ii. Open main gas valve near hood 
iii. Open secondary oxygen valve, adjust outlet pressure to < 5 psi. 
iv. Bleed oxygen line & gas line (check Little Torch Manual for which one 
to do first) 
v. Turn on the gas (small red knob) & ignite the flame.  
vi. Turn on the oxygen (small green knob) about 1/8 - ¼ turn. Slowly adjust 
oxygen & gas till the bright blue cone of flame is at its smallest.  
e. Identify a spot on the capillary that doesn’t have sample stuck to the sides. Place 
this spot in the bright blue flame. 
f. Hold capillary in torch, pulling gently, until it stretches out & seals.  
g. Also seal an empty capillary to use as a background sample. 
2. Stick capillaries onto sample holder w/double sided tape.  
a. Razor blades can be used to block out a specific region of the capillary. 
3. Setting up SAXS 
4. Check the following:  
a. Anode vacuum level : approx 2 x 10^-7 torr.  
b. Chilled water temperature: 17ºC  
5. Power up SAXS: gradually increase the kV and mA according to the chart in the manual 
and/or taped to the SAXS table, approx 2 units every 5-15 minutes. Maximum 40 kV/60 
mA.  
 
6. Put sample holder in pinhole chamber (heretofore known as PHK) 
a.  loosen the black plastic screws in the chamber to be able to pull back the prongs 
that fit into the bottom of the sample holder. 
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 b. Make sure the capillaries don’t stick too far back towards the wall, otherwise they 
may hit it & break when you scan in the y-direction. 
7. Hit “Reset” button (front panel) so that the “right side door” light turns green.   
8. Close vent valve (black cylindrical screw-cap valve, upper left-hand side of PHK).  
9. Evacuate chamber to a pressure of approx 10-2 torr, by pushing down lever marked 
“SHUT” on vac pump under SAXS table – NOT the vac pump behind the SAXS that is 
connected to the anode. 
 
10. Create a new project 
a. Under “Project Information” go to Project ? New. 
b. Type in a SampleName & SampleNumber. All your scans for this project will 
have filenames SampleName_SampleNumber_# # #.gfrm  
i. example exosurf18_1_000.gfrm 
c. Different runs within the same project can be numbered by changing the 
SampleNumber when you edit the targets (step 10.c.iii.2) 
d. Put the project in a folder 
i.  Type in a path in “Jobname”  
1. example C:\frames\2004\March\March 10\exosurf15 
ii. If the folder doesn’t exist you will be prompted to create it 
 
11. Check beamstop position (usually not necessary) 
a. Move sample holder so pinhole is not located on a capillary 
b. Collect ? Detector ? Add , 1-10 s exposure 
c. Should see a dark spot w/ approximately symmetrical corona of brightness around 
it.  
d. Record exposure time, # counts (intensity) 
e. Calculate counts/sec. Should be ~115; if differs by > 50%, realign beamstop.  
   
12. Check intensity at a given power (can also do this as part of the Radiography Scan, 
step 13.b.ii.7).  
a. Lower the glassy carbon (faucet-shaped handle on top right-hand side of PHK)  
b. Collect ? Detector ? Add for 1-10 sec 
c. Record exposure time, # counts 
d. Counts/sec should be ~ 23,000 for 40 kV x 38 mA; ~ 32,000 for 40 kV x 60 mA 
& PHK vacuum 1.5 x 10^-2 torr  
 
Example counts/sec values at 40 kV/ 60 mA 
Intensity (cts/sec) Pressure in PHK (torr) 
25923 5 x 10^-2 
42754 8 x 10^-3 
32811 1.5 x 10^-2 
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13. Radiography scan 
a. Lower the glassy carbon 
b. Locate your samples  
i. Collect ? Goniometer ? Manual 
1. Use handheld controller to move the sample-holder in X-direction 
(up-down) so that the pinhole is oriented just past the topmost 
capillary. 
2. Hit Axis Print button on controller; x and y position of that spot 
should appear on the screen. Record these. 
3. Repeat for lowest capillary.  
4. if the goniometer is not responding to manual control, make sure 
the “reset” button has been hit 
ii. Collect ? Scan ? Radiography 
1. enter x and y boundaries of the scan 
2. set 1 second per scan 
3. Do a rough scan of every 0.5 mm in X, 2 mm in Y 
4. A new window will open, color coded by intensity.  Mouse over 
the picture to get the intensity of each point (displayed in lower 
right-hand corner). Typically lower intensity corresponds to your 
sample.  
a. If the field looks uniform but you can see that capillaries 
have been passing in front of the pinhole, check to make 
sure the “reset” button has been hit & “shutter open” light 
is displaying. 
5. Once you know where the capillaries are, do a finer scan (0.25 mm 
in X and Y) to locate the best spots for diffraction pattern.  
6. Make a data table in your notebook: 
Sample Frame X 
(mm) 
Y 
(mm)
Intensity_GC 
(cts/s) 
Scan time 
(s) 
      
    (“Frame” & “scan time” will be filled in later) 
 
7. Again, mouse over each spot to find intensity. 
8. Click on them to add them to the “Targets” list, and RECORD 
THE INTENSITY FOR EACH SPOT because you’ll need it for 
the data analysis. 
9. Also click on one spot in “vacuum” area (not on one of the 
capillaries) & record its intensity. 
10. Radiography windows can be saved for future reference. They are 
all automatically named SampleName.rad and each new 
radiography scan will overwrite the other unless you save them 
under different names. 
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c. Send targets to program 
i. In the SAXS window (not the radiography window) go to Collect ? Scan 
? Accept Targets and if “Accept Targets” is not checked, click on it. 
ii. In the Radiography window, click Edit ? Send targets 
iii. In the SAXS window, Collect ? Scan ? unclick Accept targets  
iv. In the Saxs window, Collect ? Scan ? Edit Targets  
1. Change “time” for each scan to 10-60 seconds for the initial run, 
and longer for the actual data collection 
a. 15 minutes = 900 sec ; 1 hour = 3600 sec 
b. It is sometimes convenient to scan the empty capillary for a 
shorter amount of time than the sample-containing 
capillaries. An additional step in the data analysis is 
required if you do this.  
2. Targets are automatically numbered 1,2,3…; I found it useful to 
change the SampleNumber so all the targets in the first (short) scan 
were labeled 1, all the targets in the second (data-collection) scan 
were labeled 2, and so on.  
3. It may help to copy the whole list into Notepad; the SAXS 
program deletes all your changes if you accidentally close the Edit 
Targets window. 
4. This window can also be printed (Ctrl-P). 
 
d. Raise the glassy carbon.  
 
14. Scan ? Multitargets 
a. Look at each of your short scans to make sure there is a diffraction pattern. 
b. If there isn’t a pattern, either extend the scan time or look at your Radiography 
window to find a better location, and change that target in the Edit Targets 
window. 
c. Under “sequence # of ending run” enter the number of scans you wish to take. 
Example: enter “9” if the frames are numbered 000-008 
15. Repeat as necessary 
16. During scans: Ctrl-T and arrow keys let you change the display contrast.  
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II. Extraction of d-spacings using the GADDS software included with the Bruker Nanostar. 
 
A. A quick way to check d-spacing:  
1. Analyze? Cursors ? Conic produces a circle-shaped cursor centered on the diffraction 
pattern.  
2. Drag the mouse to expand/contract this circle so it traces one of the rings on the 
diffraction pattern.  
3. On the right-hand corner of the screen the d-spacing corresponding to this ring will 
appear under “Angstroms.”  
4. Rings corresponding to a lamellar structure with the same d will be integral multiples of 
each other. The second ring position will be 2x the first, the third position will be 3x the 
first, and so on.   
 
B. Integrating the whole pattern:  
This process calculates average counts/pixel for each increment of q.  
1. Peaks? Integrate ? Chi 
2. Chi determines how far around the circle to integrate.  
a.  “chi” = 360 degrees goes around the whole pattern.  
3. 2-theta determines the radius over which to integrate (i.e. the maximum value of q for 
which you want to find the average counts/pixel).  
a.  “2-theta” = 5 integrates out to the maximum q-value.  
b. At least two rings are needed to determine a structure.  
4. Step size determines how large of an increment to step out along the radius.  
a. “step size” = 0.02 is the smallest 
5. Set “normalize intensity” to “1 = Avg counts/pixel” 
6. The region corresponding to the chosen chi & 2-theta will be shown in blue, 
superimposed on the diffraction pattern.  
7. Hit “return” or left-click the mouse to integrate.  
8. A plot of I vs. 2-theta will appear superimposed on the diffraction pattern.  
9. Save the file: A prompt will appear. One of the text fields in this prompt indicates a 
location where the integrated file should be stored & will say something like 
“C:\frames\2004…” (the whole text won’t fit in the box). Click on the “Browse” button 
next to this field.  
10. A window will appear indicating folders & their contents. Click on folders until you get 
to where the raw scans are being stored. Example: in C:\frames\2004\Jan\Jan 16 there 
may be raw scans entitled SampleName_Samplenumber_xxx.gfrm.  
11. Single-click on one of these scans so its title appears in the text field at the bottom of the 
box. Change the title to SampleName_Samplenumber_xxx_AVGPX.txt (AVGPX 
indicates that you integrated it by averaging counts/pixel).  
12. Create a new folder labeled “integrated data” in the same folder that contains the raw 
scans, and open this folder so that the newly named file will go into the new folder. Hit 
“ok” or “open”. 
13. Repeat B1-12 for all scans, including that of the empty capillary but not including 
vacuum.  
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C. Subtracting the background & plotting I vs q. 
 
Isample(2θ)  = Itotal (2θ) - τs * Iglass(2θ) 
τs = (Isample + glass + GC ) / (Iglass + GC) , where “glass” denotes the quartz capillary.  
The intensity values for calculating τs come from the Radiography scan, where you 
recorded the intensities for each target with the glassy carbon in place. The values for 
Itotal(2θ) and Iglass(2θ) come from the integrated files that you saved in Step B, where 
Iglass(2θ) is from your scan of the empty capillary and Itotal(2θ) is from your sample scan.  
SigmaPlot is a quicker & more elegant way to generate the plots but Excel works too.  
In Excel:  
1. File? Open ? select the file (example: exosurf18_2_000_AVGPX.txt). A preview of 
the file appears in a gray box.   
2. Select “delimited”. Scroll down the preview to choose the row at which to start 
importing, i.e. where the comments end & the data begins. Click “Next” 
3. Another box appears. Select “Tab” and “Space” for delimiters.  
4. Hit “Next” twice, then hit “Finish” 
5. The file will appear as an Excel worksheet titled with the name of the file. The left-hand 
column shows 2-theta, the middle column shows q, and the right-hand column shows 
intensity. Paste this into another sheet as necessary for subtraction. 
6. Example layout sheet for background subtraction. “c” after filename denotes “corrected” 
for the background.  
    Wt % PEG in equil. Solution 
  EMPTY 0 0 5 5
 I_GC(cts/s) 21824 9512 15904 
2-theta Q 18-2-017 18-2-012 18-2-012c 18-2-011 18-2-011c 
0 0 3 2 0.69 5 2.81
0.02 0.001422 5 2.416667 0.24 6.166667 2.52
0.04 0.002845 5.541667 3.333333 0.92 7.333333 3.29
0.06 0.004267 32.775 15.75 1.47 32.325 8.44
0.08 0.00569 106.1731 52.61538 6.34 110.4423 33.07
0.1 0.007112 218.7344 112.9531 17.62 263.5156 104.12
0.12 0.008535 234.4306 120.6528 18.48 362.2083 191.37
0.14 0.009957 135.4783 70.13043 11.08 291.8369 193.11
0.16 0.01138 76.79 39.55 6.08 183.79 127.83
0.18 0.012802 48.75893 24.78572 3.53 115.1696 79.64
0.2 0.014225 33 16.14516 1.76 74.52419 50.48
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In Sigmaplot: set up all the raw data on one side of the sheet, then write transforms to generate 
the background-subtracted data on the other side of the sheet. 
1. Import the data 
a. File ? Import: choose your file 
SampleName_SampleNumber_xxx_AVGPX.txt  
b. Choose the row # at which to start the import.  
c. Choose the columns to import 
i. For the first file, import all the columns 
ii. For all subsequent files, import only the 2nd column (intensity) 
d. Select “white space, delimited” 
2. Make titles for each column 
a. Format ? Col & Row Titles 
b. The columns are, in order:  2θ (radians), blank, Intensity (avg cts/pixel), q 
(inverse angstroms) 
c. You can keep the 2θ column or paste the q data over it.  
d. Title the “intensity” column with some abbreviation of your sample’s name or 
filename. Example: E1010 is Exosurf + 10% PEG10K 
3. Use “transform” function to generate background-subtracted data. 
 
Example:  
Quartz capillary in col. 2 has an intensity w/glassy carbon (I_GC) of 21824 cts/s (from 
Radiography scan) & was scanned for 1800 sec. 
 sample 18-2-012 has I_GC =9512 cts/s & was scanned for 3600 sec 
 sample 18-2-011 has I_GC = 15904 cts/s & was scanned for 7200 sec 
 
1 2 3 4 5 6 7 
Q quartz 18-2-012 18-2-011  18-2-012c 18-2-011c 
0 3 2 5
0.001422 5 2.416667 6.166667
0.002845 5.541667 3.333333 7.333333
0.004267 32.775 15.75 32.325
0.00569 106.1731 52.61538 110.4423
0.007112 218.7344 112.9531 263.5156
 
To make the background-subtracted data appear in columns 6 and 7, go to the “Transform” 
window and write a new transform that is of the form:  
 Col(#) = col(sample)-(timesample/timequartz)*col(quartz)*(IGCsample/IGCquartz) 
That is,  
 col(6) = col(3)-(3600/1800)*col(2)*(9512/21824) 
 col(7) = col(4)-(7200/1800)*col(2)*(15904/21824) 
 
Then press “Apply”. The background-subtracted data should pop up in the appropriate columns. 
Save this transform window with a new filename, & you can apply it (with minor changes) in 
other notebooks as well.   
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